Four things to know:
1. The financing will be used for general corporate purposes, a company spokesperson told the publication, adding that Sequoia Capital and NewView Capital led the investment round.
2. The new funding comes nearly a year after 23andMe announced layoffs of 100 employees due to decreasing sales of its direct-to-consumer DNA test kits.
3. At a conference earlier in December, 23andMe CEO Anne Wojcicki said more than 12 million of the company’s customers agreed to participate in drug discovery research, which helped support COVID-19 research.
4. More than one million people took 23andMe’s COVID-19 study, which found that people with O blood type are between 9 percent and 18 percent less likely than others to have tested positive for COVID-19.
More articles on consumerism:
Lyft, Anthem, others launch program for individuals needing rides to COVID-19 vaccine appointments
UnitedHealthcare launches Apple Fitness+ for health plan members
Amazon launches Halo for general public: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
